Federal Flashcards

1
Q

how to cite federal law or rules/regulations

A

T USC &S(Ss)
T - title
S - section
Ss - subsection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how to cite Indiana laws

A

IC T-A-C-S
T - title
A - article
C - chapter
S - section

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how to cite Indiana rules/regulations

A

T IAC A-C-S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the definition of a drug - 4 factors

A

1 - article recognized in the official compendium
2 - article intended for use in dx, cure, tx
3 - article intended to affect body
4 - articles for use as component

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what components constitute the official compendium

A

USP, NF, HPUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is an orphan drug

A

used for a condition that affects <200,000 in the US OR affects >200,000 in the US with no expectation that the cost of developing the drug will be recovered from sales

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

who is responsible for naming generic drugs

A

USAN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

who is included in USAN

A

FDA liaison, at-large member, AMA, USP, APhA representative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is considered adulteration - 8 factors

A

1 - consists of filthy, putrid, decomposed
2 - prepared in unsanitary conditions
3 - don’t follow cGMP if manufactured
4 - container is poisonous
5 - unsafe color additive
6 - quality or purity falls below standard
7 - strength differs from compendium
8 - been in a place that denies inspection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is cGMP and the requirements

A

minimum manufacturing requirements
manufacturers MUST be registered with the FDA - failure to register = adulteration AND misbranding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how often do manufacturers have to be inspected by the FDA for cGMP

A

2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is considered misbranding - 10 factors

A

1 - labeling is false
2 - in package UNLESS contains labeling
3 - required information is missing
4 - if not recognized by official compendium
5 - not adequate directions
6 - container is misleading
7 - dose is dangerous to health
8 - color additive isn’t on label
9 - violates PPPA
10 - REMS not followed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is excluded from cGMP

A

compounded drugs
pharmacies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what factors do compounded drugs need to be exempt from cGMP, misbranding, and new drug requirements - 3 factors

A

for an individual patient
based on prescription
compounded by licensed pharmacist or physician

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

when will a pharmacy be considered an outsourcing facility (have to register)

A

compound and distribute out of state >5% of total prescriptions and have to follow cGMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

outsourcing facilities (503b) labeling requirements

A

“compounded drug”
outsourcing facility information
batch number
expiration date
storage list of ingredients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what are the medical devices and examples of each

A

class I - simple (stethoscope)
class II - need surveillance (syringe, tampon, A1C)
class III - sustain human life (pacemaker, soft contact lenses)
restricted - requires prescription due to harm (contact lenses, diaphragms)
custom - orthopedic footwear
banned - not on US market (prosthetic hair fibers, powdered gloves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

If a new device is marketed, what class would it fall under

A

class III automatically unless the FDA determines it is equivalent to a different class

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what are the classes of recalls

A

class I - serious consequence and death
class II - temporary, reversible harm
class III - no harm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what recalls are mandatory vs voluntary

A

biologics, devices, food are MANDATORY
drugs are VOLUNTARY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what is the durham-humphrey amendment of 1951

A

established qualities to make a drug prescription, who can prescribe, labeling requirements, refills

22
Q

who has authority to prescribe & who are the BIG FOUR

A

BIG FOUR - physician, dentist, veterinarian, podiatrist
NP
PA
pharmacist
OD

23
Q

prescription label requirements for FEDERAL

A

1 - name and address of dispenser
2 - serial number
3 - date filled
4 - name of prescriber
5 - name, directions, statements IF STATED

24
Q

how to decipher an NDC

A

XXXXX-XXXX-XX
first 5 = manufacturer
middle 4 = drug
last 1-2 = package size

25
Q

what is the Poison Prevention Packaging Act of 1970

A

requires special packaging (CRC)

26
Q

what is required to be considered CRC

A

at least 90% of adults can open
at least 85% of children UNDER 5 cannot open
at least 80% of children UNDNER 5 cannot open within 5 minutes after an adult showing them

27
Q

what drugs require CRC - only required for OUTPATIENT

A

PO legend drugs
Rx to OTC drugs
PO OTC drugs
sample packages for medications that require special packaging

28
Q

what drugs do NOT need special packaging - generally & 19 specific drugs

A

drugs not for PO administration (including topical application to teeth or inhalation)
1 - SL nitroglycerin
2 - SL isosorbide dinitrate <10mg
3 - erythromycin ethylsuccinate oral suspension <8g
4 - erythromycin ethylsuccinate tablets <16g
5 - anhydrous cholestyramine packets
6 - potassium supplements <50 mEq
7 - sodium fluoride liquid and tablets <264mg
8 - betamethasone tablets <12.6mg
9 - mebendazole tablet <600mg
10 - methylprednisolone tablet <84mg
11 - colestipol powder <5g
12 - pancrelipase tablet, capsule, powder
13 - ORAL contraceptives
14 - prednisone tablets <105mg
15 - conjugated estrogen tablets <32mg
16 - norethindrone tablets <50mg
17 - medroxyprogesterone tablets
18 - sacrosidase (sucrase) in glycerol and water
19 - hormone replacement therapy

29
Q

when can special packaging NOT be used if required

A

patient makes blanket waiver
prescriber provides waiver each rx basis

30
Q

which drugs require PPI and who gets them - each new rx and refill

A

INPATIENT AND OUTPATIENT
estrogen and PO contraceptives

31
Q

which drugs require MedGuides and who gets them - each new rx and refill

A

OUTPATIENT
NSAIDs, amphetamines, PPIs, mood stabilizers, opioids

32
Q

what is the Prescription Drug Marketing Act of 1987

A

to protect public health against drug diversion
prohibits drug reimportation and bans sale or trade of drugs and samples

33
Q

when can a drug be reimported into the US

A

reimported by the manufacturer
emergency use after FDA review

34
Q

how can drug samples be given

A

prescribers asks in writing to the manufacturer
hospital/clinic pharmacies can have samples for providers after the provider requests
NOT OTC

35
Q

PDMA recordkeeping and violations

A

records must be kept for 3 years
whistleblowers can get 1/2 criminal fine in rewards

36
Q

what is the federal anti-tampering act

A

for OTC
MUST have one or more barriers to entry

37
Q

what are the 5 crimes to the federal anti-tampering act

A

tampering or attempting to tamper
tainting
communicating false information that a product is tainted
threatening to tamper
conspiring to tamper

38
Q

what is the DSHEA

A

manufacturers can make claims relating to supplement’s effect on structure or function in the body if:
- related to nutrient deficiency
- describes the role of a nutrient
- characterizes mechanism
- describes general well-being

39
Q

what are the requirements for the manufacturer to market a supplement under DSHEA

A

“this has not been evaluated by the FDA”
notify FDA within 30 days of first marketing product

40
Q

is it mandatory for all drugs to use the new pregnancy categories

A

NO - drugs before June 2001 can choose which one follow. after 2001 is required in the new form

41
Q

what happens during an FDA inspection

A

for anyone that manufactures, compounds
request entry with NOI (form 482) and credentials
CAN refuse

42
Q

what happens during a DEA inspection

A

for controls
provide NOI (form 82)
if refused - will get AIW or search warrant

43
Q

what happens during BOP inspection

A

inspect without warrant and CANNOT refuse

44
Q

what are the ratings for generic substitutions

A

AA - can substitute
BX - not sufficient data CANNOT substitute
AN - bioequivalent solutions and powders for aerosolization

A can substitute
B cannot substitute

45
Q

INDA process

A

submit for each clinical trial phase - can start 30 days after submission unless denied
MUST submit annual reports to FDA

46
Q

what are the different phases in human trials

A

phase I - <100 patients without disease
phase II - <1000 patients with disease
phase III - 1000s of patients

47
Q

NDA process

A

send INDA information and FDA has 180 days to respond

48
Q

ANDA process

A

to show the drug is bioequivalent (generic drugs)

49
Q

what are the four types of REMS

A

MedGuide
communication plans
ETASU (iPLEDGE)
implementation system - review ETASU

50
Q

what is excluded from cGMP

A

compounded drugs
pharmacies

50
Q

what is the max quantity of isotretinoin prescribed for patients

A

7 days for people that can get pregnant
30 days for people that can’t get pregnant
NO REFILLS